NCT06439199View on ClinicalTrials.gov

Biological, Prospective Study Evaluating the Dosage of Plasma Cytokines Including the FLT3 Ligand and IL6 of Patients Treated With Non-intensive Chemotherapy

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

September 23, 2024

Primary Completion Date

July 15, 2026

Study Completion Date

December 15, 2026

Conditions
Acute Myeloid LeukemiaMyelodysplastic SyndromesChronic Myelomonocytic Leukemia
Trial Locations (1)

44093

RECRUITING

Nantes University Hospital, Nantes

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Nantes University Hospital

OTHER